Stuart Pocock

1.4k total citations
20 papers, 380 citations indexed

About

Stuart Pocock is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Stuart Pocock has authored 20 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 4 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Surgery. Recurrent topics in Stuart Pocock's work include Blood Pressure and Hypertension Studies (5 papers), Cardiovascular Disease and Adiposity (4 papers) and Heart Rate Variability and Autonomic Control (4 papers). Stuart Pocock is often cited by papers focused on Blood Pressure and Hypertension Studies (5 papers), Cardiovascular Disease and Adiposity (4 papers) and Heart Rate Variability and Autonomic Control (4 papers). Stuart Pocock collaborates with scholars based in United Kingdom, United States and Greece. Stuart Pocock's co-authors include Mark J. Caulfield, Markku S. Nieminen, Hans Wedel, Jan Östergren, Peter Sever, Eoin OʼBrien, Gordon T. McInnes, Björn Dahlöf, Neil R Poulter and Jesper Mehlsen and has published in prestigious journals such as The Lancet, Journal of the American College of Cardiology and Hypertension.

In The Last Decade

Stuart Pocock

17 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stuart Pocock United Kingdom	8	317	103	94	36	29	20	380
Eduardo Alegría Ezquerra Spain	14	501 1.6×	142 1.4×	107 1.1×	49 1.4×	44 1.5×	46	676
Iñaki Lekuona Spain	13	282 0.9×	54 0.5×	152 1.6×	39 1.1×	34 1.2×	49	439
Carmine Riccio Italy	13	280 0.9×	41 0.4×	125 1.3×	56 1.6×	47 1.6×	76	451
E Alegría Spain	10	266 0.8×	72 0.7×	87 0.9×	53 1.5×	8 0.3×	36	347
François Diévart France	9	191 0.6×	90 0.9×	49 0.5×	13 0.4×	20 0.7×	23	413
Nekane Murga Spain	11	305 1.0×	80 0.8×	114 1.2×	59 1.6×	55 1.9×	27	412
Lisa Naditch‐Brûlé France	13	668 2.1×	76 0.7×	44 0.5×	46 1.3×	76 2.6×	19	751
MariaGrazia Franzosi Italy	7	479 1.5×	87 0.8×	73 0.8×	68 1.9×	13 0.4×	14	626
Eva Lonn Canada	10	536 1.7×	45 0.4×	44 0.5×	104 2.9×	17 0.6×	14	668
Kadhim Sulaiman Oman	11	265 0.8×	26 0.3×	67 0.7×	44 1.2×	26 0.9×	27	355

Countries citing papers authored by Stuart Pocock

Since Specialization

Citations

This map shows the geographic impact of Stuart Pocock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Pocock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Pocock more than expected).

Fields of papers citing papers by Stuart Pocock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart Pocock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Pocock. The network helps show where Stuart Pocock may publish in the future.

Co-authorship network of co-authors of Stuart Pocock

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart Pocock. A scholar is included among the top collaborators of Stuart Pocock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart Pocock. Stuart Pocock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fuster, Valentı́n, Ana García Álvarez, Ana Devesa, et al.. (2024). Influence of Subclinical Atherosclerosis Burden and Progression on Mortality. Journal of the American College of Cardiology. 84(15). 1391–1403. 12 indexed citations

Anker, Stefan D., Martina Brueckmann, Gerasimos Filippatos, et al.. (2021). P002. Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure. Heart & Lung. 50(4). 561–561.

Bagai, Akshay, Faeez Mohamad Ali, John Gregson, et al.. (2020). MULTI-MORBIDITY, FUNCTIONAL IMPAIRMENT AND MORTALITY IN OLDER PATIENTS AFTER ACUTE MYOCARDIAL INFARCTION: A REPORT FROM THE TIGRIS REGISTRY. Journal of the American College of Cardiology. 75(11). 201–201. 1 indexed citations

Mahfoud, Felix, Raymond R. Townsend, David Kandzari, et al.. (2020). TCT CONNECT-417 Impact of Renal Denervation on Plasma Renin Activity and Relationship of Baseline Plasma Renin Activity to Blood Pressure Lowering Response to Renal Denervation in the SPYRAL HTN-OFF MED Pivotal trial. Journal of the American College of Cardiology. 76(17). B179–B179.

Sandset, Else Charlotte, Jason P. Appleton, Eivind Berge, et al.. (2019). Associations between change in blood pressure and functional outcome, early events and death. Journal of Hypertension. 37(10). 2104–2109. 2 indexed citations

Kinra, Sanjay, Vamadevan S. Ajay, Kaushik Chattopadhyay, et al.. (2019). Effectiveness and cost-effectiveness of a Yoga-based Cardiac Rehabilitation (Yoga-CaRe) program following acute myocardial infarction: Study rationale and design of a multi-center randomized controlled trial. International Journal of Cardiology. 280. 14–18. 16 indexed citations

Chattopadhyay, Kaushik, Pradeep A. Praveen, Subhash C. Manchanda, et al.. (2019). Development of a Yoga-Based Cardiac Rehabilitation (Yoga-CaRe) Programme for Secondary Prevention of Myocardial Infarction. Evidence-based Complementary and Alternative Medicine. 2019. 1–7. 8 indexed citations

Mahfoud, Felix, David E. Kandzari, Kazuomi Kario, et al.. (2019). Abstract 109: Changes in Plasma Renin Activity After Renal Denervation in the Spyral Htn-Off Med Trial. Hypertension. 74(Suppl_1).

Sorrentino, Sabato, Bimmer E. Claessen, Roxana Mehran, et al.. (2018). TCT-835 Validation of PARIS Risk Scores in Patients Treated With Everolimus-Eluting Stents for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial. Journal of the American College of Cardiology. 72(13). B333–B333. 1 indexed citations

10.

Scutt, Polly, Jason P. Appleton, Mark Dixon, et al.. (2018). Statistical analysis plan for the ‘Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2)’. European Stroke Journal. 3(2). 193–196. 4 indexed citations

11.

Fernández‐Friera, Leticia, Beatriz López‐Melgar, Belén Oliva, et al.. (2017). SUBCLINICAL ATHEROSCLEROSIS IN THE ABSENCE OF CARDIOVASCULAR RISK FACTORS: PRE-RISK STATUS IN THE PESA (PROGRESSION OF EARLY SUBCLINICAL ATHEROSCLEROSIS) STUDY. Journal of the American College of Cardiology. 69(11). 2027–2027. 1 indexed citations

12.

Fernández-Alvira, Juan Miguel, Valentı́n Fuster, Stuart Pocock, et al.. (2017). Predicting Subclinical Atherosclerosis in Low-Risk Individuals. Journal of the American College of Cardiology. 70(20). 2463–2473. 48 indexed citations

13.

Baber, Usman, Roxana Mehran, Samantha Sartori, et al.. (2014). DETECTION AND IMPACT OF SUBCLINICAL CORONARY AND CAROTID ATHEROSCLEROSIS ON CARDIOVASCULAR RISK PREDICTION AND RECLASSIFICATION IN ASYMPTOMATIC US ADULTS: INSIGHTS FROM THE HIGH RISK PLAQUE BIOIMAGE STUDY. Journal of the American College of Cardiology. 63(12). A998–A998. 8 indexed citations

14.

Woudstra, Pier, Peter Damman, Tim Clayton, et al.. (2012). ROUTINE INVASIVE VERSUS SELECTIVE INVASIVE STRATEGY AND LONG-TERM OUTCOMES IN PATIENTS WITH REDUCED RENAL FUNCTION PRESENTING WITH NON-ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME. Journal of the American College of Cardiology. 59(13). E392–E392. 1 indexed citations

15.

Yu, Jennifer, George Dangas, Usman Baber, et al.. (2012). IMPACT OF EJECTION FRACTION ON MORTALITY IN PATIENTS UNDERGOING PCI: A PATIENT-LEVEL POOLED ANALYSIS FROM THE REPLACE-2, ACUITY AND HORIZONS-AMI TRIALS. Journal of the American College of Cardiology. 59(13). E289–E289. 2 indexed citations

16.

White, Harvey D., Derek P. Chew, James W. Hoekstra, et al.. (2008). Safety and Efficacy of Switching From Either Unfractionated Heparin or Enoxaparin to Bivalirudin in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Managed With an Invasive Strategy. Journal of the American College of Cardiology. 51(18). 1734–1741. 56 indexed citations

17.

Kim, Joseph, Stephen Evans, Liam Smeeth, & Stuart Pocock. (2006). Hormone replacement therapy and acute myocardial infarction: a large observational study exploring the influence of age. International Journal of Epidemiology. 35(3). 731–738. 9 indexed citations

18.

Kim, S. Joseph, Stephen Evans, Liam Smeeth, & Stuart Pocock. (2006). Response: Response to the Stampfer commentary. International Journal of Epidemiology. 35(3). 740–740. 1 indexed citations

19.

Poulter, Neil R, Hans Wedel, Björn Dahlöf, et al.. (2005). Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA). The Lancet. 366(9489). 907–913. 207 indexed citations

20.

Remme, Willem J., Per Hildebrandt, Michel Komajda, et al.. (2003). Do patients necessarily have to start with an angiotension converting enzyme inhibitor in the treatment of heart failure? Results of the CARMEN (Carvedilol ACE Inhibitor Remodeling Mild CHF Evaluation) study. Journal of the American College of Cardiology. 41(6). 162–162. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact